Blood Hemoglobin Level and Treatment Outcome of Early Breast Cancer

[1]  M. Rose,et al.  Erythropoietin to treat head and neck cancer patients with anemia undergoing radiotherapy. , 2004, Current hematology reports.

[2]  B. Teicher.  Hypoxia and drug resistance , 1994, Cancer and Metastasis Reviews.

[3]  V. Valentini,et al.  Chemoradiation of Unresectable Pancreatic Carcinoma: Impact of Pretreatment Hemoglobin Level on Patterns of Failure , 2003, Strahlentherapie und Onkologie.

[4]  W. Sauerbrei,et al.  Multivariate Analysis of Prognostic Factors in Patients with Glioblastoma , 2003, Strahlentherapie und Onkologie.

[5]  Oliver Thews,et al.  Oxygenation Status of Gynecologic Tumors: What is the Optimal Hemoglobin Level? , 2002, Strahlentherapie und Onkologie.

[6]  Andreas Dietz,et al.  Predictive Value of the Tumor Oxygenation by Means of pO2 Histography in Patients with Advanced Head and Neck Cancer , 2001, Strahlentherapie und Onkologie.

[7]  F. Watzinger,et al.  Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. , 2001, International journal of radiation oncology, biology, physics.

[8]  P Vaupel,et al.  Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors. , 2001, Cancer research.

[9]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[10]  W. Dörr,et al.  Blood hemoglobin level may affect radiosensitivity-preliminary results on acutely reacting normal tissues. , 2000, International journal of radiation oncology, biology, physics.

[11]  S. Mercadante,et al.  Anaemia in cancer: pathophysiology and treatment. , 2000, Cancer treatment reviews.

[12]  W. Sauerbrei,et al.  Role of isolated locoregional recurrence of breast cancer: results of four prospective studies. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  H. Feldmann,et al.  Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. , 2000, International journal of radiation oncology, biology, physics.

[14]  C. Grau,et al.  Significance of Hemoglobin Concentration for Treatment Outcome , 2000 .

[15]  J. Lutterbach,et al.  Anemia is associated with decreased local control of surgically treated squamous cell carcinomas of the glottic larynx. , 2000, International journal of radiation oncology, biology, physics.

[16]  L. Sengeløv,et al.  Survival and pattern of failure following locoregional recurrence of breast cancer. , 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).

[17]  M. Piver,et al.  Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: A possible oxygen effect. , 1999, Gynecologic oncology.

[18]  B. Vikram,et al.  Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. , 1998, International journal of radiation oncology, biology, physics.

[19]  G. Sroka-Perez,et al.  THE IMPACT OF BLOOD HEMOGLOBIN CONTENT ON THE OUTCOME OF RADIOTHERAPY : THE FREIBURG EXPERIENCE , 1998 .

[20]  P. Vaupel,et al.  Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. , 1998, British Journal of Cancer.

[21]  A. Schauer,et al.  Eight-year results of a prospective non-randomised study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG). , 1998, European journal of cancer.

[22]  M. Henke,et al.  The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience. , 1998, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[23]  B. Maciejewski,et al.  Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx. , 1997, International journal of radiation oncology, biology, physics.

[24]  C. Redmond,et al.  Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. , 1995, New England Journal of Medicine.

[25]  P Okunieff,et al.  Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. , 1995, The New England journal of medicine.

[26]  D. G. Altman,et al.  Statistical aspects of prognostic factor studies in oncology. , 1994, British Journal of Cancer.

[27]  S. Krantz,et al.  Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. , 1993, The Journal of clinical investigation.

[28]  E van der Schueren,et al.  Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. , 1992, Journal of the National Cancer Institute. Monographs.

[29]  W. Jelkmann,et al.  Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. , 1992, Life sciences.

[30]  H. Thames,et al.  Clinical radiobiology of squamous cell carcinoma of the oropharynx. , 1991, International journal of radiation oncology, biology, physics.

[31]  J. Mazeron,et al.  Conservative treatment for breast cancer: long-term results (15 years). , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  S. Dische.  Radiotherapy and anaemia--the clinical experience. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  S. Piantadosi,et al.  Decreased erythropoietin response in patients with the anemia of cancer. , 1990, The New England journal of medicine.

[34]  A. Luini,et al.  Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. , 1990, European journal of cancer.

[35]  R. Arriagada,et al.  Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  R. Bush.  The significance of anemia in clinical radiation therapy. , 1986, International journal of radiation oncology, biology, physics.

[37]  D. Cox.  Regression Models and Life-Tables , 1972 .

[38]  G. Cartwright.  The anemia of chronic disorders. , 1966, Seminars in hematology.

[39]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[40]  H. Bloom,et al.  Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.

[41]  L. H. Gray,et al.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.